PV Bulletin

ARTIS Icono Ceiling, Floor and Biplane Systems Recall

Health Canada recalls ARTIS Icono imaging systems due to potential safety or performance defects.

Primary source: Health Canada

PV Impact Brief

Urgency: HighConfidence: high

What changed

Health Canada issued a recall for ARTIS Icono imaging systems due to potential safety or performance defects.

Why it matters

The defect may compromise patient or operator safety during imaging procedures.

Action needed

Identify and quarantine affected ARTIS Icono systems in inventory; contact manufacturer for update guidance.

Relevant for
Regulatory Intelligence LeadSignal Management Lead
Processes impacted
Signal ManagementLabeling
Owner

Regulatory Intelligence Lead

Review cadence

Single event

Regulatory action details

Action type
Health Product Recall
Publication date
2026-06-04
Safety issue
Recall of the ARTIS Icono imaging systems due to potential safety or performance defects.

Affected products

  • ARTIS Icono Ceiling, Floor and Biplane Systems

PV internal implications

Contact the manufacturer or distributor for guidance on necessary software or hardware updates.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jun 4, 2026

Full briefing

Practical implication

Identify and quarantine affected ARTIS Icono systems in inventory; contact manufacturer for update guidance.

Recall of ARTIS Icono Ceiling, Floor and Biplane Systems notified by Health Canada. The manufacturer or distributor should be contacted for guidance on necessary software or hardware updates.

What changed: Health Canada issued a recall for ARTIS Icono imaging systems due to potential safety or performance defects.

Why it matters: The defect may compromise patient or operator safety during imaging procedures.

Practical implication: Identify and quarantine affected ARTIS Icono systems in inventory; contact manufacturer for update guidance.

View original source

Published from the Firecrawl agent regulatory extraction pipeline.

#Safety Signals#Health Product Recall#Health Canada#safety_signal#firecrawl-agent#regulatory-extraction

Related updates for your role

publicTherapeutics Goods Administration · Australia · Updated Jul 20, 2026

Updates on ISO 14155 and N=1 Therapeutics Discussed by TGA

Urgency: High

Investigators need to modify trial protocols and safety reporting mechanisms in line with the latest ISO 14155 updates to ensure compliance for upcoming high-risk clinical trials.

Inspection ReadinessICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Notice
Read impact briefarrow_forward
publicMedicines and Healthcare products Regulatory Agency (MHRA) · United Kingdom · Updated May 23, 2026

MHRA confirms UK clinical trial safety reporting guidance is effective

Urgency: High

Safety lead to: (1) perform a UK-clinical-trial safety reporting gap assessment against MHRA’s effective guidance sections (MedDRA coding; AE/SAE; RSI governance; SUSARs; annual safety reporting; USMs; serious breaches; temporary suspension), (2) update controlled SOPs/WIs and training records to reflect “effective” status as of 28 Apr 2026, and (3) document deviations/gaps and open CAPA where needed for ongoing UK trials and new submissions.

ICSRCountry ComplianceRegulatory Intelligence Lead
SOP Impact4 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Guidance
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Jul 20, 2026

CHMP Draft Agenda for Public Consultation on Thalassaemia and Sickle Cell Disease Guidelines

Urgency: High

Sponsors and MAHs must review and align safety data collection and reporting protocols with the newly adopted guidelines while preparing for implementation of PRAC recommendations stemming from this meeting.

Signal ManagementICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Agenda
Read impact briefarrow_forward
publicSwissmedic · Switzerland · Updated Jul 17, 2026

Checklist for the Inspection of Medical Device Vigilance in Hospitals

Urgency: High

Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Checklist
Read impact briefarrow_forward